Tuesday, November 20, 2018

Investorideas.com - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (OTCQB: $GBLX) (CSE: $GABY.C) (TSXV: $HVT.C) (CSE: $CHOO.C)

Investorideas.com - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (OTCQB: $GBLX) (CSE: $GABY.C) (TSXV: $HVT.C) (CSE: $CHOO.C)

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (OTCQB: $GBLX) (CSE: $GABY.C) (TSXV: $HVT.V) (CSE: $CHOO.C)

This month's cannabis podcasts brought to you by CLS Holdings USA, Inc. (OTCQB: $CLSH) @CLSHusa

Delta, Kelowna, BC - November 20, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca and its exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
CLS Holdings USA, Inc. (OTCQB: CLSH) is a diversified cannabis company operating as Cannabis Life Sciences  an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries with plans to expand into other States.
Listen to the podcast:

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (OTCQB: $GBLX) (CSE: $GABY.C) (TSXV: $HVT.V) (CSE: $CHOO.C)

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:
Good afternoon, welcome to another Investorideas.com "potcast", featuring stocks to watch, cannabis news as well as insights from thought leaders and experts.
This month's podcast is brought to you by our exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries with plans to expand into other States.
Today we will be looking at announcements from GB Sciences, Inc. (OTCQB: GBLX), Gabriella's Kitchen Inc. (CSE: GABY), Harvest One Cannabis Inc. (TSXV:HVT) and Choom™ (CSE: CHOO) (OTCQB: CHOOF).
GB Sciences, Inc. and the Universidad de Sevilla (USE) announced the filing of a provisional patent application on the creation of myrcene-containing nanoparticles for use in the treatment of neuropathic pain.
"We have achieved a significant research milestone in the creation of the myrcene-containing nanoparticles that are at the core of our patent-pending, myrcene-based complex mixtures for the treatment of neuropathic pain," said Dr. Andrea Small-Howard. "Our colleagues at the Universidad de Sevilla had to overcome serious physical and chemical challenges to stabilize the very small myrcene molecules that are prone to evaporating. USE is also creating nanoparticle versions of the other compounds in our myrcene-containing complex mixtures; however, these other terpenoids and cannabinoids should not be as challenging because they are bigger, and USE has discovered ways to stabilize small molecules, like myrcene."
Back in October of 2017, GB Sciences, Inc. entered into a Contract Research Agreement with the Universidad de Sevilla to develop a time-released version of GB Sciences' proprietary, THC-free, myrcene-based chronic pain formulations, which contain a mixture of terpenoids and cannabinoids. USE researchers have created a prototype of the myrcene-containing nanoparticles, and GB and USE will begin functional testing of these formulations.
Gabriella's Kitchen Inc., an innovative and leading-edge cannabis wellness company, announced that it has submitted an application to have its common shares quoted on the OTCQB Venture Market (the "OTCQB") and its intention to seek The Depositary Trust Company ("DTC") eligibility. The listing of the Company's common shares on the OTCQB remains subject to the approval of the OTCQB and the satisfaction of applicable listing requirements.
The Company believes that being listed on the OTCB will expand the Company's presence in the U.S. and provide current and future U.S.-based shareholders with greater access to, and ease of trading in, GABY's shares. The Company will continue to trade on the Canadian Securities Exchange under its existing symbol "GABY".
"Admission to the OTCQB is part of our long-term strategy to introduce the Company to a broader range of institutional and retail investors in the U.S.," stated Margot Micallef, GABY's Founder and CEO. "We have established a strong operating base in the U.S. which includes products available in over 3,400 major retail locations, our cannabis manufacturing facility, and our cannabis and mainstream distribution networks. By providing U.S. investors with the opportunity to easily invest in GABY through our OTCQB listing, we fulfill yet another step in executing our strategy of becoming the category leader in the global cannabis edibles and wellness space."
Harvest One Cannabis Inc. announced that it has completed its previously announced acquisition of 100% of Israeli-based Phytotech Therapeutics Ltd. from Australian-based MMJ Group Holdings Ltd.
In consideration for the acquisition of PTL, Harvest One paid C$1,000,000 in cash and 8,326,694 Harvest One common shares.
Founded in 2014, Phytotech has developed advanced oral delivery formulations for cannabinoid-based prescription drugs and holds an exclusive worldwide licensing agreement with Yissum Research Development Company, the commercial arm of the University of Jerusalem, for a proprietary lipid nanotechnology.
With the acquisition, Harvest One's wholly-owned subsidiary Satipharm will gain access to advanced patents in favourable jurisdictions that can be used for further R&D and product development to aggressively pursue the rapidly evolving cannabis oils market.
PTL was also responsible for administrating the successful clinical trials using Satipharm's proprietary capsules. The Phase 1 clinical trials demonstrated the safety and high performance of the oral capsule technology, including the effective delivery profile of cannabidiol ("CBD"), while Phase 2 clinical trials were completed in 2017, returning favourable results in the treatment of pediatric epilepsy.
Choom™, an emerging adult use cannabis company that has secured one of the largest national retail networks in Canada, announced it has acquired Clarity Cannabis Medical Centre Inc. and affiliates doing business as Clarity Medical Centres.
Chris Bogart, President & CEO states, "Our goal is to build a dominant national cannabis retail brand. The acquisition of Clarity Medical Centres allows Choom to service the entire Canadian cannabis market, beyond just the adult use channel. As cannabis becomes more widely accepted as an alternative to pharmaceuticals, increasingly, patients with medical conditions will require professional medical advice on the benefits and best use of cannabis as a treatment."
The acquisition includes five new medical centres along with a proprietary telemedicine platform that provides important education, access and expertise for referring patients in the use of cannabis for medical purposes. The Clarity Medical Centres approach makes it simple for new patients to access legal medical cannabis products in Canada and streamlines the process of registering with a licensed producer.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

This podcast is sponsored by

CLS Holdings USA, Inc. (OTCQB: CLSH)
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that, subject to receipt of certain anticipated regulatory approvals, acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states.
CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.
For additional information, please visit: http://www.clsholdingsinc.com
Twitter: @CLSHusa

Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Disclosure this podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB: CLSH) details :
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com

No comments:

Post a Comment